Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study

Phytomedicine

Volumn 21, Issue 6, 2014, Pages 888-892

  Canevelli, Marco ^a,b   Adali, Nawal ^b,c   Kelaiditi, Eirini ^b   Cantet, Christelle ^b,d,e   Ousset, Pierre Jean ^b   Cesari, Matteo ^b,d,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CHU Mohammed VI   (Morocco)

^d INSERM   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; Cognitive impairment; Ginkgo biloba

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; GINKGO BILOBA EXTRACT; RIVASTIGMINE; PLANT MEDICINAL PRODUCT;

ACTIVITIES OF DAILY LIVING SCALE; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE SCORE; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINKGO BILOBA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; CLINICAL TRIAL; COGNITION DISORDERS; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECTS; MULTICENTER STUDY; PHYTOTHERAPY; VERY ELDERLY;

GINKGO BILOBA;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; COGNITION DISORDERS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; GINKGO BILOBA; HUMANS; MALE; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 84901246200     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2014.01.003     Document Type: Article

References (20)

1. M. Canevelli, N. Adali, C. Cantet, S. Andrieu, G. Bruno, M. Cesari, and B. Vellas Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study J. Neurol. 260 July (7) 2013 1859 1865
2. J.L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D.A. Carusi, and J. Gornbein The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308 2314
3. S.T. DeKosky, J.D. Williamson, A.L. Fitzpatrick, R.A. Kronmal, D.G. Ives, J.A. Saxton, O.L. Lopez, G. Burke, M.C. Carlson, L.P. Fried, L.H. Kuller, J.A. Robbins, R.P. Tracy, N.F. Woolard, L. Dunn, B.E. Snitz, R.L. Nahin, and C.D. Furberg Ginkgo biloba for prevention of dementia: a randomized controlled trial JAMA 300 2008 2253 2262
4. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
5. O. Fusco, A. Ferrini, M. Santoro, M.R. Lo Monaco, G. Gambassi, and M. Cesari Physical function and perceived quality of life in older persons Aging Clin. Exp. Res. 24 2012 68 73
6. R. Ihl Gingko biloba extract EGb 761®: clinical data in dementia Int Psychogeriatr 24 Suppl. 1 2012 S35 S40
7. S. Katz, A.B. Ford, R.W. Moskovitz, B.A. Jackson, and M.W. Jaffe Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function JAMA 185 1963 914 919
8. M.P. Lawton, and E.M. Brody Assessment of older people: self-maintaining and instrumental activities of daily living Gerontologist 9 1969 179 186
9. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, I. Khan, W.J. Netzer, H. Xu, and P. Butko Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 Proc. Natl. Acad. Sci. U.S.A. 99 2002 12197 12202
10. M. Mazza, A. Capuano, P. Bria, and S. Mazza Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study Eur. J. Neurol. 13 2006 981 985
11. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
12. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
13. E. Reynish, F. Cortes, S. Andrieu, C. Cantet, M. Olde Rikkert, R. Melis, L. Froelich, G.B. Frisoni, L. Jönsson, P.J. Visser, P.J. Ousset, and B. Vellas The ICTUS Study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort Neuroepidemiology 29 2007 29 38
14. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am. J. Psychiatry 141 1984 1356 1364
15. V. Schulz Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider Phytomedicine 10 Suppl. 4 2003 74 79
16. B. Vellas, N. Coley, P.-J. Ousset, G. Berrut, J.-F. Dartigues, B. Dubois, H. Grandjean, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet, and S. Andrieu Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial Lancet Neurol. 11 2012 851 859
17. S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth, and S.N. Willich Effects of Ginkgo biloba in dementia: systematic review and meta-analysis BMC Geriatr. 10 2010 14
18. A. Wettstein Cholinesterase inhibitors and Gingko extracts - are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration Phytomedicine 6 2000 393 401
19. S. Yancheva, R. Ihl, G. Nikolova, P. Panayotov, S. Schlaefke, and R. Hoerr Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial Aging Ment. Health 13 2009 183 190
20. S.H. Zarit, K.E. Reever, and J. Bach-Peterson Relatives of the impaired elderly: correlates of feelings of burden Gerontologist 20 1980 649 655